Last reviewed · How we verify
metabolic acidosis
Approved treatments
Clinical guidelines
- FDA label — 1L
Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest, and severe primary lactic acidosis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- metabolic acidosis patent landscape — cliff calendar, originator estates, attackable patents
- metabolic acidosis treatment landscape brief
- metabolic acidosis treatment updates RSS
Frequently asked questions about metabolic acidosis
What are the treatment guidelines for metabolic acidosis?
FDA label publishes guidelines for metabolic acidosis. 1 guideline references tracked.
Related
- Treatment landscape: metabolic acidosis patent cliff · metabolic acidosis CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing